Journal of Community Genetics· 2026Q2
Effect of implementation of a clinical checklist on the evaluation of constitutional mismatch repair deficiency in a neurofibromatosis clinic
- 0citations
- Q2SCImago
- 2026year
Short summary
Implementing a clinical checklist in a neurofibromatosis clinic increased the likelihood of identifying patients who meet criteria for constitutional mismatch repair deficiency (CMMRD) evaluation, with Phase 2 patients (post-checklist) more likely to be referred for genetic evaluation than Phase 1 patients (pre-checklist).
AI-generated from the title and abstract; the full text is not read.
Key points
- A clinical checklist was implemented in a neurofibromatosis clinic to improve identification of constitutional mismatch repair deficiency (CMMRD).
- Phase 2 (post-checklist) patients were more likely to meet criteria for CMMRD evaluation compared to Phase 1 (pre-checklist) patients.
- Referrals for genetic evaluation increased in Phase 2 compared to Phase 1.
- The study included 81 patients in Phase 1 and 60 patients in Phase 2.
AI-generated from the title and abstract; the full text is not read.
Abstract
BACKGROUND: Children with constitutional mismatch repair deficiency (CMMRD) require early and intensive cancer surveillance. Due to phenotypic overlap between CMMRD and neurofibromatosis type 1 (NF1), some children with CMMRD receive an incorrect diagnosis of NF1 and are inappropriately managed for their cancer risk. This study evaluated the effectiveness of a clinical checklist in identifying individuals for whom CMMRD evaluation is recommended. PROCEDURE: Providers in a neurofibromatosis clinic implemented published CMMRD evaluation checklists into their clinical notes. Phase 1 of the study consisted of retrospective chart review prior to incorporation of the checklist. Phase 2 consisted of prospective chart review after checklist implementation. RESULTS: Phase 1 included 81 patients; Phase 2 included 60 patients. In Phase 2, ambiguous ("Unknown") checklist responses were reduced, and patients were more likely to meet criteria for CMMRD evaluation. Individuals in Phase 2 were more likely to be referred for genetic evaluation compared to Phase 1. There was no correlation between patients meeting criteria for CMMRD evaluation and being referred to genetics in either cohort. CONCLUSIONS: These results suggest a clinical CMMRD checklist is a useful tool for identifying individuals for whom CMMRD evaluation is recommended. Patients with a nondiagnostic NF1 workup who meet CMMRD evaluation criteria require further follow-up to aid in appropriate diagnosis and management.
The authors' abstract, as published at the source. Journal of Community Genetics, 2026 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Neurology (Medicine)
NeurologyMedicine